Enfektif Endokarditli Hastaya Yaklaşım
Synopsis
Infective endocarditis (IE) is a fatal infection developing on heart valves, the endocardial surface, or intracardiac devices, primarily caused by staphylococci, streptococci, and enterococci. Advanced age and comorbidities increase mortality, while healthcare- and intracardiac device-related cases have recently been rising. Nonbacterial thrombotic endocarditis forms due to fibrin and platelet deposition at sites of turbulence caused by cardiac predisposing factors and comorbidities; subsequent transient bacteremia allows bacteria to settle and form vegetations. High fever is the most common clinical feature, potentially accompanied by new murmurs, heart failure, vascular, immunological, and embolic events. In diagnosis, along with clinical findings, blood cultures, and echocardiography, modalities such as cardiac CT, MRI, SPECT, and FDG-PET—which enhance sensitivity—are incorporated into the Modified Duke criteria. Diagnosis and management must be directed by a multidisciplinary IE team. Empirical or targeted bactericidal combination therapy should be maintained for at least 4–6 weeks based on culture results. Surgical intervention is indicated in cases of heart failure, uncontrolled infection, high embolic risk, and large vegetations. Antibiotic prophylaxis has been minimized and is currently recommended only for high-risk patients prior to bacteremia-producing dental procedures.
References
Murdoch DR, Corey GR, Hoen B, et al. Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study. Arch Intern Med 2009;169:463–73.
Cahill TJ, Prendergast BD. Infective endocarditis. Lancet. 2016 Feb 27;387(10021):882-93. doi: 10.1016/S0140-6736(15)00067-7.
Chu VH, Cabell CH, Benjamin DK Jr, et al. Early predictors of in-hospital death in infective endocarditis. Circulation 2004;109:1745–9.
Authors/Task Force Members, Habib G, Lancellotti P, Antunes MJ, et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015;36:3075–128.
Vieira ML, Grinberg M, Pomerantzeff PM, Andrade JL, Mansur AJ. Repeated echocardiographic examinations of patients with suspected infective endocarditis. Heart 2004;90:1020–4.
Şimşek-Yavuz S, Akar AR, Aydoğdu S, et al. [Diagnosis, treatment and prevention of infective endocarditis: Turkish consensus report]. Klimik Derg. 2019; 32(Suppl. 1): 2-116.
Fowler VG, Scheld WM, Bayer AS. Endocarditis and intravascular infections. In: Bennett JE, Dolin R, Blaser MJ, eds. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 8th ed. Philadelphia, PA: Elsevier Saunders, 2015: 990- 1028.
Prendergast BD, Tornos P. Surgery for infective endocarditis: who and when? Circulation 2010;121:1141-52.
Kang DH, Kim YJ, Kim SH, et al. Early surgery versus conventional treatment for infective endocarditis. N Engl J Med 2012;366:2466–73.
Lalani T, Chu VH, Park LP, et al. In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis. JAMA Intern Med 2013;173:1495–504.
Chu VH, Park LP, Athan E, et al. Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis. Circulation 2015;131:131–40.
Dayer M, Thornhill M. Antibiotic Prophylaxis Guidelines and Infective Endocarditis: Cause for Concern? J Am Coll Cardiol 2015;65:2077–8.